Pharmacotherapeutics
Pharmacotherapeutics
for Advanced
for Practice
Advanced for
Nurse
Practice
Advanced
Prescribers
Nurse
Practice
Prescribers
Chapter
Nurse14Prescribers
Chapter
Drugs Affecting
14Chapter
Drugsthe
Affecting
14
Respiratory
Drugsthe
Affecting
Respiratory
Systemthe
Study
Respiratory
System
Guide.pdf
Study
System
Guide.pdf
Study Guide.pdf
Pharmacotherapeu
tics for Advanced
Practice Nurse
Prescribers
Chapter 14 Drugs
Affecting the
Respiratory
System Study
Guide
Pharmacotherapeutics
Pharmacotherapeutics
Pharmacotherapeutics
for Advanced
for Practice
Advanced for
Nurse
Practice
Advanced
Prescribers
Nurse
Practice
Prescribers
Chapter
Nurse14Prescribers
Chapter
Drugs Affecting
14Chapter
Drugsthe
Affecting
14
Respiratory
Drugsthe
Affecting
Respiratory
Systemthe
Study
Respiratory
System
Guide.pdf
Study
System
Guide.pdf
Study Guide.pdf
, Pharmacotherapeutics for Advanced Practice Nurse Prescribers_ Chapter
Pharmacotherapeutics
14. Drugs Affecting the
forRespiratory
Advanced Practice
System.pdf
Nurse Prescribers_ Chapter
Pharmacotherapeutics
14. Drugs Affecting the
forRespiratory
Advanced Practice
System.pdf
Nurse Prescribers_ Chapter 14. Drugs Affecting the Respiratory System.pdf
Terms in this set (21)
Digoxin levels need to be monitored closely when the ANS: 4
following medication is started:
1. Loratadine
2. Diphenhydramine
3. Ipratropium
4. Albuterol
Patients with pheochromocytoma should avoid which of ANS: 2
the following classes of drugs because of the possibility
of developing hypertensive crisis?
1. Expectorants
2. Beta-2 agonists
3. Antitussives
4. Antihistamines
Pharmacotherapeutics for Advanced Practice Nurse Prescribers_ Chapter
Pharmacotherapeutics
14. Drugs Affecting the
forRespiratory
Advanced Practice
System.pdf
Nurse Prescribers_ Chapter
Pharmacotherapeutics
14. Drugs Affecting the
forRespiratory
Advanced Practice
System.pdf
Nurse Prescribers_ Chapter 14. Drugs Affecting the Respiratory System.pdf